Study Details

Study Objective

The purpose of this study is to see if an investigational [new/not available on the market and not yet approved by the U.S. Food and Drug Administration (FDA)] capsule is bioequivalent (to see if the active test study drug is absorbed into the body at the same rate and amount as an already approved drug)] to a currently marketed tablet, as well as to monitor the safety of the study subjects.

Study Duration

4 Visits

Study Schedule

General Screening

N/A

Medical Screening

Jan 13^th - 22^nd

Study Visit(s)

Group 1 - Period 1: Mon Jan 25^th - Wed 27^th

Group 1 - Period 2: Fri Jan 29^th - Sun 31^st

Group 1 - Period 3: Tue Feb 2nd - Thu 4th

Group 2 - Period 1: Wed Jan 27^th - Fri 29^th

Group 2 - Period 2: Sun Jan 31^th - Thu Feb 2^th

Group 2 - Period 3: Thu Feb 4^th - Sat 6^th

Other Notes

This study requires overnight stays